CD3 (immunology)
This article needs additional citations for verification. (May 2020) |
Chr. 11 q23 | |||||||
---|---|---|---|---|---|---|---|
|
Chr. 11 q23 | |||||||
---|---|---|---|---|---|---|---|
|
Chr. 11 q23 | |||||||
---|---|---|---|---|---|---|---|
|
CD3 (
Structure
The CD3γ, CD3δ, and CD3ε chains are highly related cell-surface proteins of the
A structure of the extracellular and transmembrane regions of the CD3γε/CD3δε/CD3ζζ/TCRαβ complex was solved with CryoEM, showing for the first time how the CD3 transmembrane regions enclose the TCR transmembrane regions in an open barrel.[1]
Containing aspartate residues, the transmembrane region of the CD3 chains is negatively charged, a characteristic that allows these chains to associate with the positively charged TCR chains.[2]
The intracellular tails of the CD3γ, CD3ε, and CD3δ molecules each contain a single conserved motif known as an immunoreceptor tyrosine-based activation motif, or ITAM for short, which is essential for the signaling capacity of the TCR. The intracellular tail of CD3ζ contains 3 ITAM motifs.
Regulation
Phosphorylation of the ITAM on CD3 renders the CD3 chain capable of binding an enzyme called ZAP70 (zeta associated protein), a kinase that is important in the signaling cascade of the T cell.
As a drug target
Because CD3 is required for
As a drug target in cancer research
New anticancer drug treatments are being developed based upon the CD3 T cell co-receptor, with molecules being designed for altering the co-stimulatory signal to help get the T-cell to recognize the cancer cell and become fully activated. Cancers that possess the B7-H3 immunoregulatory checkpoint receptor on the tumor cell have been one such target in clinical trials. This B7-H3 protein is expressed on cancer cell for several types of cancer. Often, the drug will contain two domains, one binding the T-cell's CD3 and the other targeting and binding cancer cells.
Immunohistochemistry
CD3 is initially expressed in the cytoplasm of pro-thymocytes, the stem cells from which T-cells arise in the thymus. The pro-thymocytes differentiate into common thymocytes, and then into medullary thymocytes, and it is at this latter stage that CD3 antigen begins to migrate to the cell membrane. The antigen is found bound to the membranes of all mature T-cells, and in virtually no other cell type, although it does appear to be present in small amounts in Purkinje cells.
This high specificity, combined with the presence of CD3 at all stages of T-cell development, makes it a useful
References
- S2CID 201665009.
- ISBN 978-1-4292-0211-4.
- PMID 31523950.
- ISBN 1-84110-100-1.
Further reading
- Shiv P, Abul KA, Andrew W (2011). Cellular and Molecular Immunology: with STUDENT CONSULT Online Access. Philadelphia: Saunders. ISBN 978-1-4377-1528-6.
External links
- Media related to CD3 (immunology) at Wikimedia Commons
- CD3+Antigens at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- Mouse CD Antigen Chart
- Human CD Antigen Chart